| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $272.4M | +11.0% |
| SG&A Expense | $108.1M | +124.7% |
| Operating Income | -$380.5M | -29.6% |
| Interest Expense | $12.7M | +220.7% |
| Income Tax | $0 | — |
| Net Income | -$373.6M | -26.5% |
| EPS (Basic) | -$19.99 | -16.0% |
| EPS (Diluted) | -$19.99 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $99.9M | -69.9% |
| Current Assets | $637.3M | +76.4% |
| Total Assets | $640.5M | +76.7% |
| Current Liabilities | $118.5M | +2.3% |
| Long-term Debt | $115.5M | +65.7% |
| Total Liabilities | $235.2M | +42.4% |
| Stockholders' Equity | $405.3M | +105.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$324.2M | -44.2% |
| Capital Expenditures | $1.5M | +581.6% |
| Investing Cash Flow | -$502.5M | -343.1% |
| Financing Cash Flow | $595.1M | +89.9% |
| Free Cash Flow | -$325.7M | -44.7% |
| -16.0% |